PBT-434

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePBT-434
Drug Alias NamePBT-434ATH-434
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynuclein alpha inhibitorsIron chelating agents
TargetsSynuclein alpha
Therapy Area/IndicationsMultiple System Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandItaly +[6
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrana Biotechnology Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMultiple System Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A